Unrecognized preclinical Alzheimer disease confounds rs-fcMRI studies of normal aging
Matthew R Brier1, Jewell B Thomas2, Abraham Z Snyder2
1From the Program in Neuroscience, Division of Biological and Biomedical Science (M.R.B.), and Departments of Neurology (J.B.T., A.Z.S., L.W., A.M.F., J.C.M., B.M.A.) and Radiology (A.Z.S., T.B., B.M.A.), School of Medicine, Washington University in St. Louis; and Hope Center for Neurological Disorders (A.M.F., T.B., B.M.A.), Knight Alzheimer's Disease Research Center (A.M.F., T.B., J.C.M., B.M.A.), and Department of Biomedical Engineering (B.M.A.), Washington University in St. Louis, MO. brierm@wusm.wustl.edu.
Objective:
To determine whether, and to what degree, preclinical Alzheimer disease (AD) confounds studies of healthy aging where "healthy" is based on cognitive normality alone.
Methods:
We examined the effects of preclinical AD in cognitively normal older individuals using resting-state functional connectivity MRI. We investigated 2 groups of cognitively normal participants: one group with evidence of preclinical AD as assessed by CSF markers of AD and the other group with normal CSF biomarkers.
Results:
There were significant interactions between age and biomarker status in the default-mode, dorsal attention, and salience resting-state networks. In the group with evidence of preclinical AD, there were dramatic changes in functional connectivity with age. In the group without evidence of preclinical AD, those changes were greatly attenuated. In most regions with significant interactions of age and biomarker status, the age-related change in functional connectivity in the normal biomarker group was indistinguishable from zero.
Conclusions:
These results suggest that preclinical AD accounts for a substantial portion of the reported effects of aging in the extant functional connectivity literature.
More Related Videos
08:43Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
Published on: August 7, 2017
09:01A Method for Investigating Age-related Differences in the Functional Connectivity of Cognitive Control Networks Associated with Dimensional Change Card Sort Performance
Published on: May 7, 2014
Related Concept Videos
01:23Alzheimer Disease ll: Pathophysiology
01:26Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
01:29Alzheimer Disease l: Introduction